Corvus Pharmaceuticals Funding: $194M Raised, Series A
Corvus Pharmaceuticals is based in Burlingame, CA. It has raised $194M in total funding. Latest round: Series A. Backed by OrbiMed Advisors.
Corvus Pharmaceuticals funding overview
Corvus Pharmaceuticals is based in Burlingame, CA. Corvus Pharmaceuticals has raised $194M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series A announced in December 2014. The round record for Corvus Pharmaceuticals runs through 2014; nothing later has been disclosed. Investors on record include OrbiMed Advisors.
Corvus Pharmaceuticals at a glance
Total raised
$194M
Latest round
Series A
Latest round date
December 2014
Headquarters
Burlingame, CA
Notable investors
OrbiMed Advisors
Frequently asked about Corvus Pharmaceuticals funding
How much has Corvus Pharmaceuticals raised?
Corvus Pharmaceuticals has raised $194M in total disclosed funding across the rounds on record.
Who has invested in Corvus Pharmaceuticals?
OrbiMed Advisors are named among the investors backing Corvus Pharmaceuticals.
What was the latest Corvus Pharmaceuticals funding round?
The most recent disclosed round is a Series A, announced in December 2014.
Where is Corvus Pharmaceuticals based?
Corvus Pharmaceuticals is based in Burlingame, CA.
When did Corvus Pharmaceuticals last raise?
The last disclosed Corvus Pharmaceuticals round closed in December 2014 at Series A.
Corvus Pharmaceuticals totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Burlingame below to benchmark round size and investor mix.
